1-4 of 4
Andreas Makris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Ke-Da Yu, Rui Zhu, Ming Zhan, Angel A. Rodriguez, Wei Yang, Stephen Wong, Andreas Makris, Brian D. Lehmann, Xi Chen, Ingrid Mayer, Jennifer A. Pietenpol, Zhi-Ming Shao, W. Fraser Symmans, Jenny C. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (10): 2723–2733.
https://doi.org/10.1158/1078-0432.CCR-12-2986
Published: 12 May 2013
View article titled, Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
Open the PDF for Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer

Mei-Lin W. Ah-See, Andreas Makris, N. Jane Taylor, Mark Harrison, Paul I. Richman, Russell J. Burcombe, J. James Stirling, James A. d'Arcy, David J. Collins, Michael R. Pittam, Duraisamy Ravichandran, Anwar R. Padhani
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6580–6589.
https://doi.org/10.1158/1078-0432.CCR-07-4310
Published: 16 October 2008
View article titled, Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Open the PDF for Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer in another window
Journal Articles

Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma

Jeremy P. Braybrooke, Andrew Slade, Gael Deplanque, Richard Harrop, Srinivasan Madhusudan, Martin D. Forster, Rachel Gibson, Andreas Makris, Denis C. Talbot, Jan Steiner, Linda White, On Kan, Stuart Naylor, Miles W. Carroll, Sue M. Kingsman, Adrian L. Harris
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1512–1520.
https://doi.org/10.1158/1078-0432.CCR-04-0155
Published: 02 March 2005
View article titled, Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma
Open the PDF for Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma in another window
Journal Articles

Prediction of Clinical Outcome from Primary Tamoxifen by Expression of Biologic Markers in Breast Cancer Patients

Jenny Chang, Trevor J. Powles, D. Craig Allred, Sue E. Ashley, Andreas Makris, R. Kate Gregory, C. Kent Osborne, Mitch Dowsett
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 616–621.
Published: 01 February 2000
View article titled, Prediction of Clinical Outcome from Primary Tamoxifen by Expression of Biologic Markers in Breast Cancer Patients
Open the PDF for Prediction of Clinical Outcome from Primary Tamoxifen by Expression of Biologic Markers in Breast Cancer Patients in another window